In last trading session, IGC Pharma Inc (AMEX:IGC) saw 0.74 million shares changing hands with its beta currently measuring 1.30. Company’s recent per share price level of $0.38 trading at $0.01 or 2.99% at ring of the bell on the day assigns it a market valuation of $29.35M. That closing price of IGC’s stock is at a discount of -139.47% from its 52-week high price of $0.91 and is indicating a premium of 34.21% from its 52-week low price of $0.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.49 million shares which gives us an average trading volume of 464.08K if we extend that period to 3-months.
For IGC Pharma Inc (IGC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.03 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
IGC Pharma Inc (AMEX:IGC) trade information
Upright in the green during last session for gaining 2.99%, in the last five days IGC remained trading in the red while hitting it’s week-highest on Monday, 12/16/24 when the stock touched $0.38 price level, adding 6.91% to its value on the day. IGC Pharma Inc’s shares saw a change of 35.31% in year-to-date performance and have moved -8.43% in past 5-day. IGC Pharma Inc (AMEX:IGC) showed a performance of 13.71% in past 30-days. Number of shares sold short was 1.22 million shares which calculate 2.29 days to cover the short interests.
IGC Pharma Inc (IGC) estimates and forecasts
Statistics highlight that IGC Pharma Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -19.26% of value to its shares in past 6 months, showing an annual growth rate of 50.00% while that of industry is 16.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -12.04% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 204k for the same. And 1 analysts are in estimates of company making revenue of 295k in the next quarter. Company posted 204k and 295k of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -13.79% during past 5 years.
IGC Pharma Inc (AMEX:IGC)’s Major holders
Insiders are in possession of 7.92% of company’s total shares while institution are holding 22.00 percent of that, with stock having share float percentage of 23.89%. Investors also watch the number of corporate investors in a company very closely, which is 22.00% institutions for IGC Pharma Inc that are currently holding shares of the company. BLACKROCK INC. is the top institutional holder at IGC for having 0.7 million shares of worth $0.31 million. And as of 2024-06-30, it was holding 1.1961 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 0.65 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.0965 of outstanding shares, having a total worth of $0.28 million.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 630.22 shares of worth $0.24 million or 1.59% of the total outstanding shares. The later fund manager was in possession of 387.25 shares on Oct 31, 2024 , making its stake of worth around $0.15 million in the company or a holder of 0.98% of company’s stock.
